#MetaplasticBreastCancer
#CaseReport

A 90-gene clinical panel on FFPE section (Ye, J Mol Diagn. 2020), in combination with IHC, to differentiate breast cancers of unknown primary

#cytojournal 2025
cytojournal.com/the-applicat...

#MetaplasticBreastCancer
N=54🇨🇳

51/54 Tri-neg
5-yr Overall Survival 68.5%

Risk factor
Axillary Lymph Node involvement
EGFR
Again, Chemotherapy (anthracycline) is Not independently associated with progression-free survival/PFS (HR=0.79 [0.43-6.33])

#Cytojournal 2024
cytojournal.com/analysis-of-...